Transcranial sonography in Wilson's disease

Parkinsonism and Related Disorders

Volumn 18, Issue 3, 2012, Pages 234-238

  Svetel, Marina ^a   Mijajlović, Milija ^a   Tomić, Aleksandra ^a   Kresojević, Nikola ^a   Pekmezović, Tatjana ^a   Kostić, Vladimir S ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Transcranial sonography; Wilson's disease

Indexed keywords

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; WILSON DISEASE;

ADULT; BASAL GANGLIA; FEMALE; HEPATOLENTICULAR DEGENERATION; HUMANS; MALE; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 84857444147     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2011.10.007     Document Type: Article

References (38)

1. Bull P.C., Thomas G.R., Rommens J.M., Forbes J.R., Cox D.W. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet 1993, 5:327-337.
2. Tanzi R.E., Petrukhin K., Chernov I., Pellequer J.L., Wasco W., Ross B., et al. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Genet 1993, 5:344-350.
3. Brewer G.J., Yuzbasiyan-Gurkan V. Wilson's disease. Medicine 1992, 71:139-146.
4. King A.D., Walshe J.M., Kendall B.E., Chinn R.J., Paley M.N., Wilkinon I.D., et al. Cranial MR imaging in Wilson's disease. Am J Roentgenol 1996, 167:1579-1584.
5. Kozić D., Svetel M., Petrović B., Dragašević N., Semnic R., Kostić V.S. MR imaging of the brain in patients with hepatic form of Wilson's disease. Eur J Neurol 2003, 10:587-592.
6. Kim T.J., Kim I.O., Kim W.S., Cheon J.E., Moon S.G., Kwon J.W., et al. MR imaging of the brain in Wilson disease of childhood: findings before and after treatment with clinical correlation. Am J Neuroradiol 2006, 27:1373-1378.
7. Sinha S., Taly A.B., Ravishankar S., Prashanth L.K., Venugopal K.S., Arunodaya G.R., et al. Wilson's disease: cranial MRI observations and clinical correlation. Neuroradiology 2006, 48:613-621.
8. Skoloudík D., Walter U. Method and validity of transcranial sonography in movement disorders. Int Rev Neurobiol 2010, 90:7-34.
9. Walter U., Behnke S., Eyding J., Niehaus L., Postert T., Seidel G., et al. Transcranial brain parenchyma sonography in movement disorders: state of the art. Ultrasound Med Biol 2007, 33:15-25.
10. Walter U., Krolikowski K., Tarnacka B., Benecke R., Czlonkowska A., Dressler D. Sonographic detection of basal ganglia lesions in asymptomatic and symptomatic Wilson disease. Neurology 2005, 64:1726-1732.
11. Berg D., Godau J., Walter U. Transcranial sonography in movement disorders. Lancet Neurol 2008, 7:1044-1055.
12. Portala K., Waldenstrom E., von Knorring L., Westermark K. Psychopathology and personality traits in patients with treated Wilson's disease grouped according to gene mutations. Ups J Med Sci 2008, 113:79-94.
13. Aggarwal A., Aggarwal N., Nagral A., Jankharia G., Bhatt M. A novel global assessment scale for Wilson's disease (GAS for WD). Mov Disord 2009, 24:509-518.
14. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960, 23:56-62.
15. Mijajlović M., Petrović I., Stojković T., Svetel M., Stefanova E., Kostić V.S. Transcranial parenchymal sonography in Parkinson's disease. Vojnosanit Pregl 2008, 65:601-605.
16. Postert T., Eyding J., Berg D., Przuntek H., Becker G., Finger M., et al. Transcranial sonography in spinocerebellar ataxia type 3. J Neural Transm 2004, 68:123-133.
17. Berg D., Roggendorf W., Schröder U., Klein R., Tatschner T., Benz P., et al. Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch Neurol 2002, 59:999-1005.
18. Hochstrasser H., Bauer P., Walter U., Behnke S., Spiegel J., Csoti I., et al. Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease. Neurology 2004, 63:1912-1917.
19. Berg D., Godau J., Riederer P., Gerlach M., Arzbetrger T. Microglia activation is related to substantia nigra echogenicity. J Neural Transm 2010, 117:1287-1292.
20. Oertel W.H., Tatsch K., Scwarz J., Kraft E., Trenkwalder C., Scherer J., et al. Decrease of D2 receptors indicated by 123I-Iodobenzamide single-photon emission computed tomography relates to neurological deficit in treated Wilson's disease. Ann Neurol 1992, 32:743-748.
21. 123I-Iodobenzamide binding. J Neural Trans 1996, 103:1093-1103.
22. Barbeau A., Friesen H. Treatment of Wilson's disease with L-dopa after failure with penicillamine. Lancet 1970, 1:1180-1181.
23. Snow B.J., Bhatt M., Martin W.R.W., Calne D.B. The nigrostriatal dopaminergic pathway in Wilson's disease studied with positron emission tomography. J Neurol Neurosurg Psychiatry 1992, 54:12-17.
24. 123I]-β-CIT demonstrates presynaptic nigrostriatal dopaminergic damage in Wilson's disease. J Neurol Neurosurg Psychiatry 1998, 65:60-64.
25. Walter U. Transcranial sonography in brain disorders with trace metal accumulation. Int Rev Neurobiol 2010, 90:167-178.
26. Roh J.K., Lee T.G., Wie B.A., Lee S.B., Park S.H., Chang K.H. Initial and follow-up brain MRI findings and correlation with the clinical course in Wilson's disease. Neurology 1994, 44:1064-1068.
27. Huang C.C., Chu N.S. Wilson's disease: resolution of MRI lesions following long-term oral zinc therapy. Acta Neurol Scand 1996, 93:215-218.
28. Naumann M., Becker G., Toyka K.V., Supprian T., Reiners K. Lenticular nucleus lesion in idiopathic dystonia detected by transcranial sonography. Neurology 1996, 47:1284-1290.
29. Becker G., Naumann M., Scheubeck M., Hofmann E., Deimling M., Lindner A., et al. Comparison of transcranial sonography, magnetic resonance imaging, and single photon emission computed tomography findings in idiopathic spasmodic torticollis. Mov Disord 1997, 12:79-88.
30. Becker G., Berg D., Rausch W.D., Lange H.K., Riederer P., Reiners K. Increased tissue copper and manganese content in the lentiform nucleus in primary adult-onset dystonia. Ann Neurol 1999, 46:260-263.
31. Mijajlovic M. Transcranial sonography in depression. Int Rev Neurobiol 2010, 90:259-272.
32. 52Fe-citrate PET study. Brain 2000, 41:781-787.
33. Vassiliev V., Harris Z.L., Zatta P. Ceruloplasmin in neurodegenerative diseases. Brain Res Rev 2005, 49:633-640.
34. Morita H., Ikeda S., Yamamoto K., Morita S., Yoshida K., Nomoto S., et al. Hereditary ceruloplasmin deficiency with hemosiderosis: a clinicopathological study of a Japanese family. Ann Neurol 1995, 37:646-656.
35. Cumings J.N. Trace metals in the brain and in Wilson disease. J Clin Pathol 1968, 21:1-6.
36. Ferrara J., Jankovic J. Acquired hepatocerebral degeneration. J Neurol 2009, 256:320-332.
37. Kim J.M., Ko S.B., Kwon S.J., Kim H.J., Han M.K., Kim D.W., et al. Ferrous and ferric iron accumulates in the brain of aged Long-Evans Cinnamon rats, an animal model of Wilson's disease. Neurosci Lett 2005, 382:143-147.
38. Peran P., Cherubini A., Luccichenti G., Hagberg G., Demonet J.F., Rascol O., et al. Volume and iron content in basal ganglia and thalamus. Hum Brain Mapp 2009, 30:2667-2675.